Integrated microfluidic device for the direct analysis of drugs and metabolites in biological fluids

点击翻译按钮获取中文摘要

Due to the way in which multiple processes are integrated in a micro Total Analysis System (µTAS), they offer substantial advantages over current technology, in terms of speed, cost of analysis, portability and operator simplicity and safety. This has considerable potential benefit for Australia, specifically for the remote and rural analysis of drugs and metabolites in biological fluids such as blood, serum, urine and saliva. These devices will have application for point-of-care testing in therapeutic drug monitoring, which will improve medical treatment and the patient's quality of life, as well as for on-site analysis in forensics for the rapid determination of illicit drugs and performance enhancing substances in our elite athletes.